| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.29 | 1e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.28 | 3e-06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.28 | 2e-05 |